Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12788/cutis.0619 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uncommon Petaloid Form of Seborrheic Dermatitis Seen in Fitzpatrick Skin Types V-VI.
J Clin Investig Dermatol
July 2023
Department of Dermatology, Boonshoft School of Medicine at Wright State University, Dayton Ohio.
Background: Seborrheic dermatitis (SD) is an inflammatory disease that has a papulosquamous morphology in areas rich in sebaceous glands such as the scalp, face, and body folds. Petaloid SD is an uncommon presentation found in patients with dark skin (Fitzpatrick Skin type V-VI). This form of SD can appear as pink or hypopigmented polycyclic coalescing rings or scaly macules and patches in the typical areas SD appears, which can mimic other conditions including lupus erythematosus.
View Article and Find Full Text PDFMammary Paget's Disease Presenting as an Annular Plaque.
Acta Dermatovenerol Croat
December 2022
Shiro Niiyama, MD, PhD Department of Dermatology, Toho University Ohashi Medical Center Ohashi, Meguro-ku, Tokyo, Japan
Dear Editor,Mammary Paget's disease (MPD) is an adenocarcinoma localized within the epidermis of the nipple and/or the areola of the breast, and it is as a rule associated with a carcinoma of the underlying lactiferous ducts, where it usually starts. MPD is relatively rare, observed in 0.7-4.
View Article and Find Full Text PDFProton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
J Cosmet Dermatol
December 2022
Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
Purpose: Previous knowledge about the association between proton pump inhibitors (PPIs) exposure and subacute cutaneous lupus erythematosus (SCLE) was mainly based on limited case reports or few review studies. We aim to evaluate the clinical characteristics, management, and outcome in patients with PPIs-induced SCLE.
Methods: Case reports and case series from 2000 to December 31, 2021, on SCLE induced by PPIs were collected and retrospectively analyzed.
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.
Clin Exp Dermatol
April 2022
Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
We report on a patient who presented with refractory subacute cutaneous lupus erythematosus. The scaly annular and polycyclic patches/plaques, and hyperkeratotic lesions on multiple fingers improved rapidly after treatment with baricitinib.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!